期刊文献+

榄香烯注射液辅助治疗肺癌脑转移患者的临床疗效观察 被引量:1

Clinical Observation of Elemene Injection in the Adjuvant Treatment of Brain Metastasis from Lung Cancer
下载PDF
导出
摘要 目的探讨榄香烯注射液辅助治疗肺癌脑转移患者的临床疗效。方法通过对2016年10月至2018年10月在我院治疗的122例肺癌脑转移患者随机分组,对照组患者应用放疗,实验组患者应用化疗辅助榄香烯注射液治疗,观察比较两组治疗效果、生活质量、不良反应发生率差异。结果实验组总缓解率为55.74%(34/61),对照组总缓解率为34.43%(21/61),差异有统计学意义(P<0.05)。实验组生理状况评分为(18.53±1.25)分,社会/家庭状况评分为(20.71±2.07)分,情感状况评分为(17.94±1.99)分,功能状况评分为(17.57±2.62)分,对照组生理状况评分为(15.11±1.09)分,社会/家庭状况评分为(17.69±1.85)分,情感状况评分为(15.12±1.64)分,功能状况评分为(14.73±1.96)分,差异有统计学意义(P<0.05)。实验组不良反应发生率37.70%(23/61),对照组不良反应发生率为72.13%(44/61),差异有统计学意义(P<0.05)。结论针对肺癌脑转移患者应用榄香烯注射液辅助治疗可提高治疗效果和患者生活质量,降低不良反应发生率,值得推广应用。 Objective To investigate the clinical efficacy of elemene injection in the treatment of patients with lung cancer with brain metastases.Methods A total of 122 patients with brain metastases from lung cancer who were treated in our hospital from October 2016 to October 2018 were randomized.Patients in the control group were treated with radiotherapy.Patients in the experimental group were treated with chemotherapy-assisted elemene injection.Differences in treatment outcomes,quality of life,and incidence of adverse reactions.Results The total remission rate was 55.74%(34/61)in the experimental group and 34.43%(21/61)in the control group,with a statistically significant difference(P<0.05).In the experimental group,the scores were(18.53±1.25),social/family status(20.71±2.07),emotional status(17.94±1.99),functional status(17.57±2.62),physiological status(15.11±1.09),social/family status(17.69±1.85),emotional status(15.12±1.64),and functional status The difference was statistically significant(P<0.05).The incidence of adverse reactions was 37.70%(23/61)in the experimental group and 72.13%(44/61)in the control group,the difference was statistically significant(P<0.05).Conclusion The application of elemene injection in the treatment of lung cancer patients with brain metastases can improve the therapeutic effect and quality of life of patients,and reduce the incidence of adverse reactions.It is worthy of popularization and application.
作者 李雪 张申众 袁秀敏 门桐林 张璐 王艳 LI Xue;ZHANG Shen-zhong;YUAN Xiu-min;MEN Tong-lin;ZHANG Lu;WANG Yan(Department of Oncology,The Tenth People's Hospital of Shenyangy,Shenyang 110044,China)
出处 《中国医药指南》 2020年第14期161-162,共2页 Guide of China Medicine
关键词 榄香烯注射液 辅助治疗 肺癌 脑转移 Elemene injection Adjuvant therapy Lung cancer Brain metastasis
  • 相关文献

参考文献6

二级参考文献51

  • 1齐彩霞,安永恒.化疗药物透过血脑屏障的研究进展评价[J].中国医院用药评价与分析,2007,7(1):31-34. 被引量:10
  • 2蒋向阳,安曙光,汪超,肖鑫,刘克,丁刚.卡氮芥对肺癌中枢神经系统转移的预防作用及毒性探讨[J].临床肺科杂志,2007,12(4):362-363. 被引量:1
  • 3石安辉,朱广迎,余荣,马惠民,刘长青,苏星,孙艳,蔡勇,徐晓娜,张珊文,徐博.非小细胞肺癌伴脑转移放疗疗效分析[J].中华肿瘤杂志,2007,29(7):545-548. 被引量:15
  • 4陈红.磁共振弥散成像对脑肿瘤周水肿区的诊断价值[J].中国实验诊断学,2007,11(12):1625-1627. 被引量:6
  • 5Sorensen JB, Hansen HH, Hansen M, et al. Brain metastases in adenocarcinoma of the lung: Frequency, risk groups, and prognosis[J]. J Clin Oncol, 1988, 6(9):1474-1480.
  • 6Hendriks LE, Smit EF, Vosse BA, et al. EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?[J]. Lung Cancer, 2014,84(1):86-91.
  • 7Welsh JW, Komaki R, Amini A, et al. Phase Ⅱ trial of Erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer[J]. J Clin Oncol, 2013, 31(7): 895-902.
  • 8Sperduto PW, Kased N, Roberge D, et al. Summary report on the graded prognostic assessment: An accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases[J]. J Clin Oncol, 2012, 30(4):419-425.
  • 9Iuchi T, Shingyoji M, Sakaida T, et al. Phase Ⅱ trial of Gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma[J]. Lung Cancer, 2013,82(2):282-287.
  • 10Zhou L, He J, Xiong W, et al. Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase Ⅰ dose-escalation study[J]. Lung Cancer,2016, 96: 93-100.

共引文献83

同被引文献17

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部